137 related articles for article (PubMed ID: 28807607)
21. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy.
Gilbert PB; Fong Y; Juraska M; Carpp LN; Monto AS; Martin ET; Petrie JG
BMC Infect Dis; 2019 May; 19(1):453. PubMed ID: 31117986
[TBL] [Abstract][Full Text] [Related]
22. The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations.
Frasca D; Diaz A; Romero M; Blomberg BB
Vaccine; 2016 May; 34(25):2834-40. PubMed ID: 27108193
[TBL] [Abstract][Full Text] [Related]
23. Preterm infants' T cell responses to inactivated poliovirus vaccine.
Klein NP; Gans HA; Sung P; Yasukawa LL; Johnson J; Sarafanov A; Chumakov K; Hansen J; Black S; Dekker CL
J Infect Dis; 2010 Jan; 201(2):214-22. PubMed ID: 20017631
[TBL] [Abstract][Full Text] [Related]
24. Effect of apoptosis-associated speck-like protein containing a caspase recruitment domain on vaccine efficacy: Overcoming the effects of its deficiency with aluminum hydroxide adjuvant.
Lee DK; Lee EY; Kim RH; Kwak HW; Kim JY; Kim H; Kang KW; Lee SM; Park JH; Chang J; Nam JH
Microbiol Immunol; 2018 Mar; 62(3):176-186. PubMed ID: 29315762
[TBL] [Abstract][Full Text] [Related]
25. Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children.
Nolan T; Bravo L; Ceballos A; Mitha E; Gray G; Quiambao B; Patel SS; Bizjajeva S; Bock H; Nazaire-Bermal N; Forleo-Neto E; Cioppa GD; Narasimhan V
Vaccine; 2014 Oct; 32(46):6146-56. PubMed ID: 25223266
[TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
Munoz FM; Jackson LA; Swamy GK; Edwards KM; Frey SE; Stephens I; Ault K; Winokur P; Petrie CR; Wolff M; Patel SM; Keitel WA
Vaccine; 2018 Dec; 36(52):8054-8061. PubMed ID: 30416018
[TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
Englund JA; Walter E; Black S; Blatter M; Nyberg J; Ruben FL; Decker MD;
Pediatr Infect Dis J; 2010 Feb; 29(2):105-10. PubMed ID: 19934787
[TBL] [Abstract][Full Text] [Related]
28. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.
Tsatsaris V; Capitant C; Schmitz T; Chazallon C; Bulifon S; Riethmuller D; Picone O; Poulain P; Lewin F; Lainé F; Jacqz-Aigrain E; Aboulker JP; Launay O;
Ann Intern Med; 2011 Dec; 155(11):733-41. PubMed ID: 22147712
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age.
Karron RA; Steinhoff MC; Subbarao EK; Wilson MH; Macleod K; Clements ML; Fries LF; Murphy BR
Pediatr Infect Dis J; 1995 Jan; 14(1):10-6. PubMed ID: 7715982
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.
Nolan T; McVernon J; Skeljo M; Richmond P; Wadia U; Lambert S; Nissen M; Marshall H; Booy R; Heron L; Hartel G; Lai M; Basser R; Gittleson C; Greenberg M
JAMA; 2010 Jan; 303(1):37-46. PubMed ID: 20026597
[TBL] [Abstract][Full Text] [Related]
31. Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS.
Chambers CD; Johnson DL; Xu R; Luo YJ; Louik C; Mitchell AA; Schatz M; Jones KL;
Vaccine; 2016 Aug; 34(37):4443-9. PubMed ID: 27449682
[TBL] [Abstract][Full Text] [Related]
32. Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial.
Nunes MC; Cutland CL; Jones S; Hugo A; Madimabe R; Simões EA; Weinberg A; Madhi SA;
JAMA Pediatr; 2016 Sep; 170(9):840-7. PubMed ID: 27380464
[TBL] [Abstract][Full Text] [Related]
33. Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability.
D'Angio CT
Paediatr Drugs; 2007; 9(1):17-32. PubMed ID: 17291134
[TBL] [Abstract][Full Text] [Related]
34. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.
Chambers CD; Johnson D; Xu R; Luo Y; Louik C; Mitchell AA; Schatz M; Jones KL;
Vaccine; 2013 Oct; 31(44):5026-32. PubMed ID: 24016809
[TBL] [Abstract][Full Text] [Related]
35. Antibody response to the influenza vaccine in healthcare workers.
Sacadura-Leite E; Sousa-Uva A; Rebelo-de-Andrade H
Vaccine; 2012 Jan; 30(2):436-41. PubMed ID: 22064268
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.
Hakim H; Allison KJ; Van de Velde LA; Tang L; Sun Y; Flynn PM; McCullers JA
Vaccine; 2016 Jun; 34(27):3141-3148. PubMed ID: 27129426
[TBL] [Abstract][Full Text] [Related]
37. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
Belshe RB; Frey SE; Graham IL; Anderson EL; Jackson LA; Spearman P; Edupuganti S; Mulligan MJ; Rouphael N; Winokur P; Dolor RJ; Woods CW; Walter EB; Chen WH; Turley C; Edwards KM; Creech CB; Hill H; Bellamy AR;
JAMA; 2014 Oct; 312(14):1420-8. PubMed ID: 25291578
[TBL] [Abstract][Full Text] [Related]
39. Measuring antibody responses to a live attenuated influenza vaccine in children.
Lee MS; Mahmood K; Adhikary L; August MJ; Cordova J; Cho I; Kemble G; Reisinger K; Walker RE; Mendelman PM
Pediatr Infect Dis J; 2004 Sep; 23(9):852-6. PubMed ID: 15361726
[TBL] [Abstract][Full Text] [Related]
40. Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore.
Lau YF; Tang LH; Chien Lye D; Ooi EE; Leo YS
Hum Vaccin Immunother; 2017 Mar; 13(3):551-560. PubMed ID: 28277090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
